A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
To evaluate the bioequivalence of two formulations of Sarpogrelate HCl 300mg, Anpl‐one SR Tab. 300mg (Reference) and generic Sarpogrelate HCl 300mg (Test), after a single oral dose administration in healthy Thai volunteers under feeding condition: open label, single‐dose, randomized, two‐period, two‐treatment, two‐sequence, crossover, comparative bioavailability study
Epistemonikos ID: 279f0a735c35a422dbde6dad988a241eb64226d5
First added on: May 21, 2024